Epigenetic Modification and Acetylation of Androgen Receptor Regulate Prostate Cellular Growth

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-60327-079-3_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells

  2006cited by this paper
• SIRT1 and endocrine signaling.

  2006cited by this paper
• Hormonal Control of Androgen Receptor Function through SIRT1

  2006cited by this paper
• Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription.

  2006cited by this paper
• Epigenetic regulation of nuclear steroid receptors.

  2006cited by this paper
• Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.

  2005cited by this paper
• Androgen receptor corepressors: An overview

  2005cited by this paper
• Global histone modification patterns predict risk of prostate cancer recurrence

  2005cited by this paper
• LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

  2005cited by this paper
• Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor γ-mediated Adipogenesis through Histone Deacetylase Recruitment*

  2005cited by this paper
• Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction.

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

  2005cited by this paper
• High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines.

  2005cited by this paper
• Fatty acid synthase: A metabolic oncogene in prostate cancer?

  2004cited by this paper
• The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity*

  2004cited by this paper
• SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.

  2004cited by this paper
• Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair.

  2004cited by this paper
• Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.

  2004cited by this paper
• Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.

  2004cited by this paper
• ATP-dependent nucleosome remodelling: factors and functions

  2004cited by this paper
• Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies.

  2003cited by this paper
• Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth

  2003cited by this paper
• p300 in prostate cancer proliferation and progression.

  2003cited by this paper
• Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

  2003cited by this paper
• Acetylation in hormone signaling and the cell cycle.

  2002cited by this paper
• Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function

  2002cited by this paper
• Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor*

  2002cited by this paper
• Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity*

  2001cited by this paper
• NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae

  2001cited by this paper
• Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

  2001cited by this paper
• NHEJ regulation by mating type is exercised through a novel protein, Lif2p, essential to the ligase IV pathway.

  2001cited by this paper
• A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

  2001cited by this paper
• p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation*

  2000cited by this paper
• Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis

  1999cited by this paper
• The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

  1999cited by this paper
• Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae

  1997cited by this paper
• Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

  1996cited by this paper
• The Bromodomain of Cbp And/or P300 Interaction between Acetylated Myod And

  year unknowncited by this paper

• No citing papers are available for this paper.